OUHSC Research News – Monday, December 20, 2021
Notices and Reminders
In alignment with the University’s closure for the upcoming Winter Break, the Office of the Vice President for Research (VPR) including ORA will be closed on December 23, 2021 through December 31, 2021, reopening on January 3, 2022.
Any proposals or other items due to sponsors during this time must be submitted to ORA within three business days before the campus closure dates. Any contracts expiring December 31, 2021 need to be in our office by December 13, 2021. Should you need urgent assistance during the holiday closure, please contact ORA at HSCORA@ouhsc.edu. All other matters will be addressed when the University reopens for regular business hours.
Effective October 1st, the NIH requires all NIH-funded clinical trials to complete clinical trial registration 21 days after enrollment of first participant and/or results reporting 12 months after trial actual primary completion date. NIH has now enhanced checks on non-compliance for these two requirements in the eRA System. Failure to comply with NIH timeline will delay your Research Performance Progress Report (RPPR) submission. NIH has also placed additional scrutiny on all aspects of RPPRs that has resulted in a significant increase in rejected reports from OUHSC investigators.
Because of these substantial changes and additional information requirements (including Other Support format), all RPPRs are now subject to additional review by ORA.
Effective January 1, 2022, ORA MUST receive RPPRs for review 3 business days prior to the sponsor deadline for single-project grants and 5 business days prior to the sponsor deadline for multi-project grants.
For more information on NIH enhanced checks on non-compliance, please see: https://nexus.od.nih.gov/all/2021/11/09/enhanced-checks-for-compliance-with-clinical-trial-registration-and-reporting-in-rppr/
We are fast approaching NIH January Deadline (i.e. January 25, 2022). Your assistance in notifying us of your intention to submit a proposal for the upcoming deadline and submitting the final proposal package according to the ORA proposal submission policy will help ensure a smooth and successful submission.
ORA Reminder: Effective October 1st, ORA requires applicants and recipients to use the updated Other Support format to submit with applications, Just-In-Time (JIT) and Research Performance Progress Reports (RPPRs).
Because of the substantial changes and additional information that needs to be included, all Key Personnel on RPPRs are expected to provide Other Support in the updated format for each RPPR, regardless of when Other Support was last submitted for key personnel. Failure to follow the appropriate format on or after October 1st, may delay processing your application/award by the ORA staff.
ORA Reminder: As a friendly reminder, please make sure you are carefully checking PeopleSoft and the budget justification to make sure OU Norman personnel are not included in the OUHSC personnel line. Failure to properly list the OUHSC vs Norman personnel in the budget preparation phase may result in a rebudget request from the sponsor, and could negatively impact processing of the award.
Requirements for Acknowledging NIH-Supported Research
NIH funded researchers are required to accurately acknowledge NIH funding in publications, press releases, or other documents about research that is funded by NIH in whole or in part. To comply with NIH requirements, recipients must include the following (as described in Communicating and Acknowledging Federal Funding):
Recipients should only acknowledge NIH awards on publications and other documents when the research activities that contributed to that publication directly arise from the award and are within the scope of the award being acknowledged. Please see the Communicating and Acknowledging Federal Funding and FAQs pages for more information on when, where, and how to acknowledge NIH funding.
Interested in becoming an IRB Member?
The OUHSC Institutional Review Board (IRB) currently has openings for new IRB members. The IRB reviews applications and reports for human research projects to ensure that the rights and welfare of human participants are protected and that risk of harm is minimized.
If you are interested in medical or social science research and would like to be involved with protecting the rights, safety and welfare of individuals who volunteer to participate in research, IRB membership may be for you. Current members have expressed that of all the committee’s they have participated in, the IRB has been the most rewarding. Members enjoy an increased understanding of research and exposure to cutting edge issues and current controversies in medical diagnostics and treatments. In addition, valuable collaboration may result from working closely with board members from a variety of disciplines.
If you are interested in learning more about IRB membership, please contact the HRPP Office at 405-271-2045 or email to email@example.com.
Workshops and Seminars
NSF EPSCoR Professional Development Seminar Series: Getting the Most from Your Team's Science
Date: 1/24/22, 12:00-1:00 p.m. (Central)
Description: Faculty, postdoctoral researchers, and university students interested in pursuing a career in research are invited to participate in the Oklahoma NSF EPSCoR Professional Development Seminar Series. The first seminar of 2022, “Getting the Most from Your Team’s Science,” has been scheduled for Monday, January 24, from noon to 1:00 p.m. (Central Time). The meeting will be presented via Zoom by Dr. L. Michelle Bennett, Director, Center for Research Strategy, National Cancer Institute, and Chief Innovation Officer, Acting, National Institute of Environmental Health.
Login Information: http://www.okepscor.org/calendar/ok-nsf-epscor-professional-development-seminar-series-2
OUHSC Funding Opportunities
Presbyterian Health Foundation Research Grants Program - 2022
Description: This grant program funds multiple types of projects and has enabled the progression of pioneering concepts to research studies, the establishment of renowned clinicians and basic scientists transdisciplinary teams unifying a broad range of expertise and skills, the development of extremely talented junior faculty, the provision of infrastructure support for faculty to continue ground-breaking research, and more.
Click here to learn more about the 2022 opportunities.
If you have any questions, please email ORA4PHF@ouhsc.edu.
Link to Full Announcement: https://research.ouhsc.edu/Resources/PHF-Funding-2022
American Cancer Society Institutional Research Grant (ACS-IRG) – Underrepresented Minority Focus
Description: The ACS-IRG is a unique source of funding entrusted to Stephenson Cancer Center (SCC) that provides seed money for early-stage faculty interested in cancer-related research - the ACS has provided SCC with supplemental monies that allow support for one pilot grant specifically directed towards an underrepresented minority (URM) investigator.
Eligibility: Full time Assistant Professors within six years of their first independent faculty appointment and with no active peer-reviewed research funding from national funding agencies (e.g. NIH, DOD, NSF, ACS) may apply.
Proposals Due: January 7, 2022
Link to Full Announcement: Please refer to the attached flyer for application link and guidelines.
Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email firstname.lastname@example.org or email@example.com).
- Travere Therapeutics is seeking an academic research collaboration focused on polycystic kidney disease (ADPKD, ARPKD). Out of scope: drug repurposing, diagnostics. Preference is for opportunities with evidence of novel mechanism and POC data. Submission entails a 1-pg non-confidential summary of technology (deadline 1/5).
- A global pharmaceutical company (requested anonymity) is seeking innovative small molecule regulators of RNA transcripts that are highly selective toward their targets for treating immunologically based diseases. Out of scope: oligotherapeutics, gene therapy approaches, viral delivery. Submission entails a 1-pg non-confidential summary of technology (deadline 1/5).
- Bayer Crop Science is interested in collaborating with academia to identify novel and/or engineered protein candidates that can be produced in plant cell cultures or transformed plant systems for applications in food, agriculture, sustainability, consumer health, pharmaceuticals or other industries. Out of scope: products with a small potential market. Submission entails a 1-pg non-confidential summary of technology (deadline 1/12).
- Roivant Sciences is seeking key opinion leaders/advisors to collaborate in developing a universal influenza vaccine program based on differentiated RNA technology. Areas of interest include delivery systems for RNA, adjuvants, and modified nucleosides. RNA-based technologies that have no potential application to respiratory diseases are out of scope. Submission entails a 1-pg non-confidential summary of technology (deadline 1/12).
- Notice of Cancellation of the April 2022 Application Receipt Date for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed"
- Notice to Extend Eligibility for Submission of NIGMS Applications to PA-20-188, "NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)" Due to COVIDrelated Disruptions
- Notice to Extend the Response Date for NOT-OD-21-187 "NIH Request for Information (RFI): Search Capabilities across the Biomedical Landscape for NIH-wide Data Discovery"
- Notice to Extend Eligibility for Submission of K99/R00 Pathway to Independence Award Applications Due to COVID-Related Disruptions
- Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in PAR-21-189, Medical Scientist Training Program (T32)
- Notice of Additional Receipt Cycle for T32 Grant Applications
- Notice to Extend Eligibility for Submission of "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)" Applications Due to COVIDrelated Disruptions
- Notice of NIGMS Participation in NOT-OD-22-030, "Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional)"
- Notice of NIGMS Participation in NOT-OD-22-031, "Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)"
- Notice of Change in Expiration Date for PAR-19-372, "Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)"
- Notice of Participation of National Institute on Minority Health and Health Disparities (NIMHD) in RFA-AG-23-004, "Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed)"
- Notice of Correction to Due Dates for PAR-22-028, "Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)"
- Notice of Early Expiration of NOT-OD-21-127 Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects
- Notice of Early Expiration of NOT-OD-21-137, Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects
- Notice of Intent to Publish a Funding Opportunity Announcement for Immune Drivers of Autoimmune Disease (U01 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
- Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities
Other Funding Opportunities
The Oklahoma Highway Safety Office (OHSO) Highway Safety Projects for the FFY2023
Description: The Oklahoma Highway Safety Office (OHSO) announces the opening of the pre-application process for highway safety projects for the FFY2023, which starts in October 2022 and runs through September 2023. The OHSO receives funds annually from the National Highway Traffic Safety Administration (NHTSA) to promote traffic safety initiatives within the State of Oklahoma.
The OHSO solicits applications for highway safety grant projects designed to support the mission to combat the number and severity of traffic crashes by developing and supporting educational, enforcement, and engineering programs. The programs addressed by OHSO grants include, but are not limited to impaired driving, occupant protection and child passenger safety, pedestrian and bicycle safety, driver education programs and motorcycle safety.
Pre-application Due: January 7, 2022
Link to Full Announcement: Please use this link to access the form.
OHSO CONTACT: DeAngela Gaymon, Deangela.Gaymon@dps.ok.gov
The Tobacco Settlement Endowment Trust (TSET)
Description: To identify and respond to emerging opportunities to transform and improve the health of
Oklahomans, TSET will accept unsolicited proposals in two areas of emphasis. Proposals must identify immediate, impactful opportunities to positively transform and improve the health of Oklahomans. Proposals must be project-driven, time-limited, have a specific targeted area or population in mind, be supported by multiple partners, and agree to participate in an external evaluation of the project.
Unsolicited proposals are accepted for projects related to the following areas identified as priorities by the TSET Board of Directors:
- Policy and built environment change: up to $350,000 per project per year for up to two years
- Innovations in active living and healthy eating: up to $250,000 per project per year for up to two years
Proposals Due: March 15, 2022
Link to Full Announcement: https://tset.ok.gov/content/other-funding-opportunities
NIH technology accelerator challenge for maternal health
Description: The National Institute of Biomedical Imaging and Bioengineering (NIBIB), with the support of its partners, is offering up to $1,000,000 in cash prizes for innovative diagnostic technologies to help improve maternal health around the world.
The NIH Technology Accelerator Challenge for Maternal Health (NTAC: Maternal Health) seeks to spur and reward the development of prototypes for low-cost, point-of-care molecular, cellular, and/or metabolic sensing and diagnostic technologies to guide rapid clinical decision-making, improve patient outcomes, and ultimately prevent maternal morbidity and mortality.
To win NTAC: Maternal Health, participants must: (1) Submit their design for a point-of-care diagnostic test or platform technology with initial feasibility data or references addressing at least two of the four priority conditions listed below affecting maternal health during antenatal and intrapartum periods; and (2) Submit a robust description of the proposed path for translation and further development of the diagnostic technology for use in global health settings. Additionally, diagnostics should be fully integrated digital health platforms. The four priority conditions and specific examples are as follows:
- Infection: viral, bacterial, or parasitic infections; sepsis; post-procedural infections
- Hypertensive disease: pre-eclampsia; eclampsia
- Hemorrhage: acute anemia; iron deficiency anemia; coagulopathy
- Placental issues: angiogenic or other markers of placental disruption
Proposals Due: April 1, 2022
Link to Full Announcement: https://venturewell.org/ntac/
Telligen Community Initiative (TCI) philanthropy - 2022 REQUEST FOR PROPOSALS
Description: Grants of up to $50,000 to Illinois, Iowa, Colorado, and Oklahoma nonprofits, schools, and agencies for programs that support creative ways to bring innovation and equity to the health sector and recruiting and generating pathways to a high-quality health care workforce. Programs can also emphasize novel approaches to positively address the social determinants of health.
All current TCI grants are for periods of one year. Cycle 1 awardees (OK or CO) begin on June 1, 2022.
Proposals Due: February 28, 2022
Link to Full Announcement: http://telligenci.org/grants
OKLAHOMA NSF EPSCoR Research Seed Grant Funding Opportunity
Description: The Oklahoma NSF EPSCoR program is announcing the availability of funding to stimulate high-risk, high-impact, and potentially transformative research to develop and test science-based solutions for complex (“wicked”) problems at the intersection of land use, water availability, and infrastructure in OK. Seed Grant proposals will be accepted by OK NSF EPSCoR from any Oklahoma institution of higher education. Funding will be awarded for projects of up to 1-year duration. The maximum award amount for a single award is $75,000; however, smaller proposals are encouraged.
Proposals Due: January 15, 2022
Link to Full Announcement: http://www.okepscor.org/sites/default/files/u6/2022%20OK%20NSF%20EPSCoR%20Seed%20Grant%20Guidance.pdf
NSF Integrative Research in Biology (IntBIO)
Description: This solicitation invites submission of collaborative proposals that tackle bold questions in biology and require an integrated approach to make substantive progress. Integrative biological research spans subdisciplines and incorporates cutting-edge methods, tools, and concepts from each to produce groundbreaking biological discovery. The research should be synergistic and produce novel, holistic understanding of how biological systems function and interact across different scales of organization, e.g., from molecules to cells, tissues to organisms, species to ecosystems and the entire Earth. Such knowledge is critical to inform solutions to societal challenges, including natural resource management, resilience to environmental change, and global food security. Outcomes from integrative research will also inform and guide the development of new technologies that drive the nation's bioeconomy.
Proposals Due: January 25, 2022
Link to Full Announcement: https://www.nsf.gov/pubs/2021/nsf21622/nsf21622.htm
NSF Major Research Instrumentation Program: (MRI)
Description: The Major Research Instrumentation (MRI) Program serves to increase access to multi-user scientific and engineering instrumentation for research and research training in our Nation's institutions of higher education and not-for-profit scientific/engineering research organizations. An MRI award supports the acquisition or development of a multi-user research instrument that is, in general, too costly and/or not appropriate for support through other NSF programs.
Proposals Due: January 19, 2022
Link to Full Announcement: https://www.nsf.gov/pubs/2018/nsf18513/nsf18513.pdf
Diabetes Research Wellness Foundation – Research Grants
Description: DRWF accepts research applications related to finding the cause, prevention, treatment, and cure of diabetes and its complications. The maximum support of these grants is up to $50,000 per year for up to 2 years. If the proposed research is within an area of primary interest and is judged as having high scientific merit by the Foundation’s advisors, the Board of Directors may make special grant awards that exceed the stated maximum. Currently, the Foundation’s area of primary interest and focus are islet cell transplantation, macrovascular disease & neuropathy. All other research proposals will not be reviewed.
Proposals Due: December 30, 2021
Link to Full Announcement: https://www.diabeteswellness.net/apply-funding
Cystic Fibrosis Foundation
Clinical Research Award and Clinical Pilot and Feasibility Award: Full application (Invite-Only) deadline January 25, 2022.
First and Second Year Clinical Fellowships - Application deadlines March 2, 2022
Third and Fourth Year Clinical Fellowships - Application deadlines: February 16, 2022
Fifth+ Year Clinical Fellowships - Application deadlines: February 16, 2022
LeRoy Matthews Physician-Scientist Award - Application deadlines: February 16, 2022
Harry Shwachman Clinical Investigator Award - Application deadlines: February 16, 2022
Additional Open Funding Opportunities can be found here.
Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP)
Fiscal Year 2022 (FY22) pre-announcements
Ovarian Cancer Research Program (OCRP)
- Investigator - Initiated Research Award
- Ovarian Cancer Academy Award - Early-Career Investigator
- Pilot Award
- Teal Expansion Award
- Proteogenomics Research Award
- Omics Cancer Academy - Clinical Trial Award
- Clinical Trial Award
Tuberous Sclerosis Complex Research Program (TSCRP) (https://cdmrp.army.mil/pubs/press/2022/22tscrppreann)
- Exploration – Hypothesis Development Award
- Idea Development Award
- Clinical Translational Research Award
The Mselanoma Research Alliance (MRA) 2021-2022 Request for Proposal
Team Science Award Full Proposals Due (from invited applicants) Due: January 19, 2022
Description: MRA anticipates supporting at least $12.8 million in new funding. Proposals will be accepted for Team Science, Academic-Industry Partnership, Young Investigator, and Pilot Awards. Special Opportunities are also available in immunotherapy, women in research, and patient-centric clinical trials. MRA encourages applications from a diverse pool of investigators. Full descriptions of each award opportunity offered, including all Special Opportunity Awards, as well as eligibility criteria and instructions can be found on the MRA website at CureMelanoma.org/RFP
Proposals should be submitted via the proposalCENTRAL online application tool: https://proposalcentral.com/
Oklahoma Center for Adult Stem Cell Research (OCASCR)
Grant Deadline: January 28, 2022